Meningeal CarcinomatosisCytarabineInjections, SpinalPolyradiculopathyLiposomesLeukemic InfiltrationDrug EvaluationDaunorubicinIdarubicinLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsRemission InductionDrug CarriersConsolidation ChemotherapyMitoxantroneAmphotericin BDoxorubicinAntimetabolites, AntineoplasticArabinonucleosidesLeukemia, MyeloidDrug Administration ScheduleEtoposidePolyethylene GlycolsTreatment OutcomeVincristineThioguanineMethotrexateAntibiotics, AntineoplasticInduction ChemotherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaAntifungal AgentsAntineoplastic AgentsDisease-Free SurvivalDrug Delivery SystemsSurvival AnalysisCyclophosphamideCytidine MonophosphateLymphoma, Non-HodgkinSalvage TherapySurvival RateAcute DiseaseRecurrenceCarmustineAsparaginaseDrug AgonismNystatinDeoxycytidine KinaseLeukemia, Myelomonocytic, Acute6-MercaptopurineArabinonucleotidesCombined Modality TherapyInfusions, IntravenousCentral Nervous System NeoplasmsLeukemia, Myeloid, Accelerated PhaseDose-Response Relationship, DrugDexamethasoneAmsacrineVidarabineChemistry, PharmaceuticalArabinofuranosylcytosine TriphosphateTransplantation, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug Resistance, NeoplasmMeningitisAnthracyclinesDeoxycholic AcidTeniposideAnemia, Refractory, with Excess of BlastsNeutropeniaMyelodysplastic Syndromes